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Abstract
Background: The purpose of the FABO-study is to evaluate the effect of family-based behavioral social facilitation
treatment (FBSFT), designed to target children’s family and social support networks to enhance weight loss outcomes,
compared to the standard treatment (treatment as usual, TAU) given to children and adolescents with obesity in a
routine clinical practice.
Methods: Randomized controlled trial (RCT), in which families (n = 120) are recruited from the children and adolescents
(ages 6–18 years) referred to the Obesity Outpatient Clinic (OOC), Haukeland University Hospital, Norway. Criteria for
admission to the OOC are BMI above the International Obesity Task Force (IOTF) cut-off ≥ 35, or IOTF ≥ 30 with obesity
related co-morbidity. Families are randomized to receive FBSFT immediately or following one year of TAU. All participants
receive a multidisciplinary assessment. For TAU this assessment results in a plan and a contract for chancing specific
lifestyle behaviors. Thereafter each family participates in monthly counselling sessions with their primary health care nurse
to work on implementing these goals, including measuring their weight change, and also meet every third month for
sessions at the OOC. In FBSFT, following assessment, families participate in 17 weekly sessions at the OOC, in which each
family works on changing lifestyle behaviors using a structured cognitive-behavioral, socio-ecological approach targeting
both parents and children with strategies for behavioral maintenance and sustainable weight change.
Outcome variables include body mass index (BMI; kg/m2), BMI standard deviation score (SDS) and percentage above
the IOTF definition of overweight, waist-circumference, body composition (bioelectric impedance (BIA) and dual-X-ray-
absorptiometry (DXA)), blood tests, blood pressure, activity/inactivity and sleep pattern (measured by accelerometer), as
well as questionnaires measuring depression, general psychological symptomatology, self-esteem, disturbed eating and
eating disorder symptoms. Finally, barriers to treatment and parenting styles are measured via questionnaires.
Discussion: This is the first systematic application of FBSFT in the treatment of obesity among youth in Norway. The
study gives an opportunity to evaluate the effect of FBSFT implemented in routine clinical practice across a range of
youth with severe obesity.
Trial registration: ClinicalTrails.gov NCT02687516. Registered 16th of February, 2016
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Background
There has been a global increase in the prevalence and
severity of overweight and obesity amongst both adults
and children [1, 2]. The World Health Organization
(WHO) states that childhood obesity is one of the most
serious public health challenges of the 21st century [2].
Childhood obesity is associated with a wide array of
negative health consequences such as psychosocial prob-
lems, obstructive sleep apnea, increased cardio-metabolic
risk and Type 2 Diabetes [3–5], resulting in considerable
burden for the individual child as well as socio-economic
consequences [6, 7]. In addition, childhood obesity has
great impact on adulthood, and is associated with adult
obesity [8] and all-cause mortality in adulthood [9]. A re-
cent study [9] with 2.3 million participants between the
ages of 16 and 19 years found that a graded increased risk
for cardiovascular and all-cause mortality during 40 years
of follow-up started among participants with a body mass
index (BMI; kg/m2) currently accepted within the normal
range (from 50th to 74th percentiles).
The need for developing potent treatments for child-
hood obesity has been recognized for decades and a sub-
stantial body of treatment research exists [10–12]. There
is also substantial evidence indicating that it is difficult
to get more than modest weight loss when treating ado-
lescents with severe obesity [13, 14].
Several reviews and meta-analyses have summarized the
results of different childhood obesity treatments and pro-
vided recommendations as to which treatments are the
most efficacious and which treatment components are pre-
dictive of favorable treatment outcomes [11, 12, 15, 16].
Specifically, lifestyle interventions that teach behavioral
techniques that focus on incorporating the behavior
changes into daily life routines, and are delivered in a
family-based format (i.e., targeting both the child and
parent), seem to be the most efficacious treatment for
childhood obesity [11, 15–18]. However, it is important
to note that much of this research has been conducted
within efficacy trials. Thus, effectiveness trials, which
focus on the applicability and validity of the treatment
in usual health care settings with a less selected group
of participants, are warranted, as few have been con-
ducted [19].
Childhood obesity treatment of medium-to high intensity
and longer duration have been found to be most efficacious
[20]. Best effect for treatments that included more than 26
sessions are found in one review [20]. There is however
some discussion about how prolonged the treatment needs
to be to yield meaningful weight loss outcomes. For in-
stance, one review suggests that interventions that last
about four months are as efficacious as treatments of longer
duration [21]. A meta-analyses of intervention studies from
2002–2015 [18] finds that weight loss treatment for
children has evolved over the past decade, especially in
that recent studies report longer duration and follow-up
than in the 1990s [18]. Despite these findings that indicate
the importance of higher-intensity treatment, many
national guidelines for addressing childhood obesity
recommend weight surveillance and brief lifestyle
counseling in primary care service for children with
obesity and their families [22]. However, this approach
is not effective, at least not for children and adoles-
cents with severe obesity [22, 23].
Recently, there has been consensus that obesity is a
disease [24]. Classifying obesity as a chronic health condi-
tion increases the understanding of the fact that extended
follow-up after an intensive treatment phase is necessary
for weight loss maintenance. Long-term maintenance of
treatment effects is a challenge with obesity treatment
across both adults and children [25–27]. Family-based be-
havioral treatments for childhood obesity have, importantly,
demonstrated promising long-term effects compared to
other treatments [15, 28]. A ten-year follow-up study found
that 34 % of the participants who entered the treatment
program at age 6–12 had reduced their percent overweight
by at least 20 %, and 30 % had BMIs that were no longer in
the obese range [28].
Dropout is a substantial concern in treatment of both
adult and pediatric obesity [11, 29, 30], but only a limited
number of studies have examined the predictors for drop-
out [29, 31, 32]. Studies show mixed results regarding bar-
riers to treatment participation. Some studies have found
higher number of barriers in families who end the treat-
ment program prematurely [32, 33], while another found
few differences in degree of barriers among treatment com-
pleters compared to non-completers [31]. Post-treatment
reported barriers in prior studies include high degree of
family stressors, parent-adolescent conflict, lack of time and
interest, interference with school schedules, disappointment
with amount of weight-loss, and treatment taking place too
far from home [31, 32, 34]. Further research on predictors
for dropout and barriers to treatment participation, both
among non-completers and completers, has important im-
plications for clinical practice [30].
Another subject of clinical importance is to identify pre-
treatment factors related to poorer treatment response. To-
gether with knowledge about predictors for dropout and
barriers to treatment participation, these factors can iden-
tify at risk groups and tailor childhood obesity treatment to
increase treatment response. Several pre-treatment factors
have been associated with weight loss outcomes in previous
research on childhood obesity treatment [30, 31, 35–38],
including child age, gender, child initial weight status
[36, 38], child mental health problems [36, 37], and par-
ents’ degree of motivation [30, 31, 35, 36]. However,
there seems to be a lack of studies investigating the in-
fluence of family variables and broader social network
support as predictors of treatment response.
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The aim of this paper is to describe and explain the
design and evaluation of the Family-based behavioral
treatment of childhood obesity (FABO)−study targeting
children and adolescents with obesity and their families.
The description of the study protocol follows the checklist
of the CONSORT statement for randomized trials [39]
(Additional files 1 and 2).
Methods/Design
Intervention
Family-based behavioral social facilitation treatment
(FBSFT) is founded on the principles of standard family-
based behavioral treatment for obesity, which is the most
well documented approach for childhood obesity [11].
FBSFT has an intensive treatment phase including weekly
family meetings over 17 consecutive weeks with the same
health care worker at the Obesity Outpatient Clinic (OOC),
Haukeland University Hospital, Norway. All the health care
workers on the multidisciplinary treatment team at the
OOC are trained in FBSFT prior to treatment delivery. The
multidisciplinary team consists of a pediatrician, nutritionist,
physiotherapist, nurse and psychologist. Throughout the
study period, the treatment team will have weekly meetings
to discuss the patients in addition to monthly supervision
sessions with the research team in St. Louis, MO, USA and
Pittsburgh, PA, USA through video-conferences.
There are session-specific components and goals for each
of the 17 sessions (see Table 1 for complete outline). The
treatment targets healthy lifestyle changes in both the chil-
dren and parents in the areas of diet, physical activity, sed-
entary activity, sleep and social function. The dietary and
physical activity guidance used in the study is based on the
Traffic Light Diet [40] in which foods and activities are or-
ganized into green, yellow and red groups. Green meaning
“go,” yellow meaning “sometimes” and red meaning “limit.”
The treatment focuses on implementing the behavior
change across all the different settings in the family mem-
bers’ daily lives (i.e., within the home/family environment,
peer network environment, community environment).
Through the treatment sessions, the families are taught
a set of behavioral and cognitive techniques for promoting
healthy behavior change and dealing with mechanisms
that maintain unhealthy lifestyle behaviors:
 Self-monitoring. Both the parents and children
monitor their eating, weight and activity on a
week-to-week basic going through the intensive
treatment phase
 Goal setting, planning and reward systems
 Stimulus control
 Emotion regulation strategies
 Reframing negative automatic thoughts
 Communication and interpersonal skills
 Parenting strategies
 Healthy modeling from the parents
 Healthy methods of self-evaluation and self-assertion
After the intensive treatment phase, the families receive
monthly follow-up treatment for 18 months through col-
laboration between specialty and primary care: monthly
follow-up sessions with their school nurse (primary care)
and follow-up sessions every third month at the OOC. The
focus for these sessions is maintenance of healthy habits.
For families assigned to standard treatment (treatment
as usual, TAU), the treatment consists of a post-assessment
meeting between a health care worker at the OOC and the
family, agreeing on behavioral goals for changing lifestyle, a
plan for the implementation of new behaviors and goals for
weight loss. Each family also participates in monthly coun-
selling session with their local health care nurse to work on
implementing these goals, including measuring their weight
change, and also meets every third month for sessions at
the OOC for assessments, evaluation of progress and
revision of goals. TAU is delivered over the course of
12 months.
Study objectives and hypotheses
The objectives and hypotheses of the current study are:
 To evaluate the effect of FBSFT compared to TAU
for severe childhood and adolescent obesity in a
common health care setting. The primary outcome
is weight status, assessed as BMI, BMI standard
deviation scores (SDSs) and percentages above
the IOTF cut-off for overweight (%IOTF-25)
[41]. Secondary outcomes are other weight-
related anthropometric measurements (waist
circumference (WC) and Waist-to-height ratio
(WHtR) and corresponding SDSs), body composition
(BIA, DXA), blood test, blood pressure, eating habits,
sleep, physical activity as well as psychological
well-being and parenting style.
○ We hypothesized that FBSFT will be superior to
TAU in improving these parameters both during
the intensive treatment period and during the
follow-up period.
 To identify predictors of treatment success and
treatment drop out with a focus on family variables,
socioeconomic status, social network and mental health.
○ We expect children from families in which both
parents participate in treatment to demonstrate
better weight loss outcome and have lower
dropout rate.
○ We expect children of parents living together to
demonstrate better treatment effects and have
lower dropout rate.
○ We expect that parental (self-reported) weight
status will influence treatment effects and dropout
Skjåkødegård et al. BMC Public Health  (2016) 16:1106 Page 3 of 9
rate; higher BMI category will predict poorer
treatment effects and higher dropout rate.
○ We expect that lower socio-economic status
and limited social network will predict poorer
treatment effects and higher dropout rate.
○ We expect poorer treatment effect and higher
dropout rate among participants with
psychological comorbidities.
 To evaluate experienced barriers to treatment, and
how these factors influence children’s and parents
treatment response. Barriers to treatment are
classified into four groups: competing activities/life
stressors, relevance of treatment, treatment issues
(logistics) and critical events.
○ We expect lower degree of competing activities/
life stressors to predict better treatment
response and lower dropout rate.
○ We expect higher degree of experienced
treatment relevance to predict better treatment
response and lower dropout rate.
○ We expect lower degree of treatment issues
and lower number of critical events to
predict better treatment response and lower
dropout rate.
 To evaluate FBSFT implementation and
acceptability for children, parents and health
care workers. This is an exploratory study using
a brief interview to investigate parents’, children’s
and health care workers’ experiences with the
treatment.
Trial design
The FABO-study is a randomized clinical trial (RCT)
using a wait-list control design in which all recruited
families of children with severe obesity will receive FBSFT
at some point. All families go through initial assessments
at the Obesity Outpatient Clinic (OOC) at Haukeland
University Hospital, and can choose to give informed
consent to participate. If informed consent is given, the
families are randomized to either FBSFT (arm A) or
TAU followed by FBSFT one year later (arm B). The
overall study design is summarized in Fig. 1. Flow sheet
for the FABO-study.
Blinding
The data manager and statisticians are blinded to group
allocation until analyses are conducted. Blinding of par-
ticipants and/or the treatment team was not possible
due to the nature of the study.
Inclusion criteria
The sample will consist of 120 children and adoles-
cents (aged 6–18 years) referred to the OOC by their
general practitioner. Criteria for admission to the
clinic is an International Obesity Task Force (IOTF)
BMI ≥ 35, or ≥ 30 [41] with obesity related co-morbidity.
The child/adolescent participates in the treatment to-
gether with her/his family, such that both the child and a
least one of the parents agree to actively participate in the
treatment.
Table 1 Session topics in family-based behavioral facilitation treatment (FBSFT)
Phase Session FBSFT Topic
1. Individual and Home Contex 1-2 Introduction to the treatment; plan for the Traffic Light Diet; personalized treatment plan
3 Healthy and regular eating, communicating with the family about lifestyle changes
4 Sedentary activity; sleep routines
5 Physical activity; lifestyle activity
6 Creating a healthy family and home environment; problem solving skills
7 Healthy self-instructions; emotions/stress and eating behavior
2. Peer Contex 8 Peers as a support for healthy behaviors (arranging healthy activities with others); assessment
of social network
9 High risk situations (parties, holidays and vacations); prompts for eating and physical activity
10 A healthy peer environment; communicating with peers about new and healthy habits
11 Taking on Teasing
3. Community Contex 12 Physical activity and the assessment of RED food in the environment/neighborhood
13 To be active in your neighborhood; join groups or teams; to elicit support for healthy habits in your
neighborhood/environment
14 To fight weight stigmatization; influences from the media; to build a positive self-image and body image
15 High risk situations (restaurants and fast food); to focus on healthy habits at school and work
4. Cross-contextual 16 To plan for healthy habits; relapse prevention and consolidating skills across different contexts
17 Reviewing goals and skills; ending well; planning ahead
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Exclusion criteria
Families are excluded if either the children or parents
experience severe somatic or psychiatric illness that
affect weight or adherence to the treatment program,
or current participation in other obesity treatment
programs.
Strategies to improve adherence to intervention protocol
A standardized checklist for data collection for each
child/adolescent participating in the study is created
after randomization. Once per month the checklists
are reviewed, and participants with missing data are
reminded by either text message or phone call to
Fig. 1 Flow sheet for the FABO-study
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complete the assessments. In the intensive treatment phase
of FBSFT, sessions are rescheduled so that each family
receives the same content, while delivering the sessions
within a 6 month period. Sessions are rescheduled within
the week when possible, and are combined with the next
session or delivered by phone if the family is unable to
attend (e.g., due to weather or driving conditions, schedul-
ing conflicts). Health care workers meet weekly for on-site
supervision of intervention delivery, and monthly for Skype
supervision with the research team in St.Louis, MO, USA
and Pittsburgh, PA, USA.
Sample size
One hundred twenty families will be recruited, with 60
families in each treatment arm. Power estimates were
calculated using G*Power, version 3.1.3. [42, 43] With
two treatment groups (TAU, FBSFT), 3 measurement
points (pre-treatment, 6 months post-treatment and
12 month post-treatment) and a correlation of 0.5 be-
tween the measurement points, alpha .05, power .80, a
small (f = 0.10), moderate (f = 0, 25) and high (f = 0.40)
effect size would demand respectively sample sizes of
164, 28 and 12 participants to detect a significant group
X time interaction on the primary outcome. For regres-
sion analysis of predictors of treatment outcome, a
small to moderate effect size is expected (f = 0.15), and
when testing the increase in R2 by adding 1 predictor
to an analysis including 5 predictors in total, a sample
size of 55 persons will be needed.
Randomization
After informed consent is given and the initial assessment
is completed, each participant is randomly allocated to
either receive FBSFT immediately (arm A) or following
one year of TAU (arm B). The randomization is performed
by the pediatrician and allocation to the two groups is
done by extracting a random, sealed envelope from a
sealed folder. At the beginning of the study, there were
120 sealed envelopes: 60 with the letter A (for arm A) and
60 with the letter B (for arm B).
Outcome measures
Measurement points are pre-treatment, post-treatment
(i.e., 6 months from pre-treatment), at 12 months, 18 months
and 24 months. See Fig. 1 for overview.
Anthropometrical measures
Trained assessors at the OOC will measure height and
weight for calculation of BMI (kg/m2), WC and body com-
position (measured with bio impedance (BIA), InBody 720).
BMI will be converted to SDS using the extended IOTF
[41, 44] BMI references. The percentage of the IOTF 25
threshold (%IOTF-25) is calculated as 100*(BMI/IOTF
25), where BMI is the child’s weight divided by height
squared (kg/m2), and IOTF 25 is the BMI that corresponds
to the IOTF threshold for overweight for the child’s age
and sex. Dual-energy X-ray absorptiometry (DXA)-scans
for determining the distribution of fat and muscle tissue
will be conducted at the Department of Rheumatology at
Haukeland University Hospital.
Physiological measures
Blood samples will be drawn in the morning after an
overnight fast and include measurements of total-
cholesterol, high density lipoprotein (HDL), low-density
lipoprotein (LDL), triglycerides (TG), aspartate transamin-
ase (ASAT), alanine transaminase (ALAT), creatinine, gly-
cated hemoglobin (HbA1c) and fasting insulin, c-peptide
and glucose, thyroid stimulating hormone (THS), free thy-
roxine (fT4), and C-reactive protein (CRP). A bio-bank for
the storing and registering of biological materials has been
approved. Trained assessors at the OOC will measure
blood pressure.
Physical activity and sleep patterns
Physical activity and sleep patterns will be measured
using Actiwatch 2 (Phillips). The actiwatch devices are
wrist-worn accelerometers that records all uni-axial
movement over 0.05G in thirty-second epochs. The acti-
watch will be worn on the non-dominant wrist for seven
consecutive days. A wrist-worn accelerometer was chosen
over hip-worn accelerometers to ensure compliance [45].
Wrist-worn accelerometers are validated for use both as a
measure of physical activity, inactivity and sleep and are
recommended for use in studies evaluating lifestyle inter-
ventions for obesity among children and adults [46–48].
Psychological measures
The following five questionnaires will be used in the
study:
The Child Behavior Checklist (CBCL) [49], a 138-item
scale assessing behavioral and emotional symptoms in
children that has both a child/youth and parent form.
Several studies have provided evidence of the instruments
psychometric properties and stability [49–51].
Children’s Depression Inventory (CDI) [52], a 27-item
self-report measure assessing the cognitive, affective and
behavioral symptoms of depression in children (7–17 years).
The psychometric properties of the scale have generally
been found to be acceptable [53, 54].
Self-Perception Profile for Children (SPPC) [55], a self-
report measure of self-perception or self-esteem in children
aged 8 to 14 years widely used for research purposes. The
questionnaire includes 36 statements and the children are
asked to evaluate to which degree the statement fits their
thoughts about themselves. The internal reliability has been
demonstrated to be high [56].
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The Dutch Eating Behavior Questionnaire Child
version (DEBQ) [57], a measure of disordered eating
behaviors in children and youth. DEBQ consists of
three sub-scales: emotional eating, external eating, and re-
strained eating. The questionnaire is increasingly used for
research on youth with overweight and psychometric
properties have in general been found acceptable [58, 59].
The Youth Eating Disorder Examination-Questionnaire
(YEDE-Q) [60], a self-reported measure of eating patterns
and eating disorder psychopathology. The YEDE-Q is a
self-report version of the Child Eating Disorder Examin-
ation (ChEDE) and was designed to include measurements
of binge eating in youth [61]. The YEDE-Q has been vali-
dated using the ChEDE as an assessment of eating-related
pathology in overweight youth [61].
Other measurements
Barriers to treatment participation scale (BTPS) [62], a
44-item scale developed and validated to address drop-
out from treatment with out-patient psychological treat-
ment of children and adolescents. The scale is found to
yield high levels of internal consistency and to be pre-
dictive of treatment dropout and weeks spent in treat-
ment [62, 63].
The Parenting Scale (PS) [64], 30-item questionnaire
designed to measure different parental disciplines with
children and youth. The scale is widely used for research
and clinical purposes. The internal consistency and test-
retest stability have been found to be acceptable to good,
and the validity of the instrument has been demon-
strated in several studies [65, 66].
Planned data analysis
A two-way MANOVA with one repeated-measure factor
(Time: pre-intervention/post-intervention), and one
between-group factor (Treatment Group: FBSFT vs.
TAU) will be conducted to assess the impact of treat-
ment on primary and secondary outcomes.
A one way within-subjects MANOVA will be used to
analyze the effect of time (pre-treatment, post-treatment,
12-, 18-, 24 months post treatment) on primary and sec-
ondary outcomes.
In order to identify factors associated with treatment
success and treatment drop out, multiple regression
analyses will be conducted. The dependent variables
are %IOTF-25 and drop-out status (yes/no). The predictors
are: both parents participating in treatment, parental mari-
tal status, self-reported parental weight, socio-economic
status and social network, psychological comorbidities.
In order to identify barriers to treatment and how
these barriers influence children’s and parents’ treatment
response, multiple regression analyses will be conducted.
The dependent variable is %IOTF-25. The predictors
are: competing activities/life stressors, relevance of treat-
ment, treatment issues (logistics) and critical events.
Intention-to-treat analyses will be conducted and ef-
fect sizes calculated for treatment effects.
Time plan for the FABO-study
In this study, we aim to recruit 120 families of children
with severe obesity. Enrollment of families to the study
began in January 2014 and we anticipate that recruit-
ment will be completed by Autumn 2017.
Discussion
To our knowledge, this study is the first RCT conducted
in Scandinavia evaluating the effect of family-based behav-
ioral treatment of childhood and adolescent obesity deliv-
ered in a chronic care model that comprises specialty care
and routine clinical practice. The 2011 guidelines from
the Norwegian Directorate of Health concerning treat-
ment of overweight children [67], recommend the use of
more structured family-based behavioral treatments for
severely obese children. However, the availability of such
programs has been limited, as well as the possibilities to
get training in delivering this type of treatment. This study
offers an opportunity to evaluate the effect of this treat-
ment in routine clinical practice. After the study period,
FBSFT is likely to be considered as a standard option for
treatment, then as a part of stepped care treatment, mean-
ing that non-responders to standard care will advance to
this more intensive and targeted treatment.
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